<!DOCTYPE html>
<!-- saved from url=(0083)https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/d11095.htm -->
<html class="" data-reactroot=""><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script src="./1095.再生障碍性贫血 - 搜狗科学百科_files/analytics.js.download" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app209.us.archive.org';v.server_ms=449;archive_analytics.send_pageview({});});</script>
<script type="text/javascript" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/bundle-playback.js.download" charset="utf-8"></script>
<script type="text/javascript" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/wombat.js.download" charset="utf-8"></script>
<script type="text/javascript">
  __wm.init("https://web.archive.org/web");
  __wm.wombat("https://baike.sogou.com/kexue/d11095.htm","20221025114441","https://web.archive.org/","web","/_static/",
	      "1666698281");
</script>
<link rel="stylesheet" type="text/css" href="./1095.再生障碍性贫血 - 搜狗科学百科_files/banner-styles.css">
<link rel="stylesheet" type="text/css" href="./1095.再生障碍性贫血 - 搜狗科学百科_files/iconochive.css">
<!-- End Wayback Rewrite JS Include -->
<meta name="save" content="history"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="baidu-site-verification" content="VWGb6TyYx8"><meta content="再生障碍性贫血 - 搜狗科学百科" name="keywords"><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"><meta http-equiv="x-dns-prefetch-control" content="on"><meta name="server" baike="235" ip="210" env="online"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://cache.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://hhy.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://pic.baike.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://ugc.qpic.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://xui.ptlogin2.qq.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://q1.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://q2.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://q3.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://q4.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://q.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://img01.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://img02.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://img03.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221025114441/https://img04.sogoucdn.com/"><link rel="Shortcut Icon" href="https://web.archive.org/web/20221025114441im_/https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link rel="Bookmark" href="https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link href="./1095.再生障碍性贫血 - 搜狗科学百科_files/base_b849887.css" rel="stylesheet"><link href="./1095.再生障碍性贫血 - 搜狗科学百科_files/detail_378aed5.css" rel="stylesheet"><link href="./1095.再生障碍性贫血 - 搜狗科学百科_files/inviteAudit_7894507.css" rel="stylesheet"><link rel="stylesheet" href="./1095.再生障碍性贫血 - 搜狗科学百科_files/highlight.min.css"><title>再生障碍性贫血 - 搜狗科学百科</title><style>.onekey-close {
	position: absolute;
	top: 16px;
	right: 16px;
	width: 24px;
	height: 24px;
	background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	text-indent: -999em;
	background-size: 84px;
	background-position: -63px 0;
}

.onekey-login {
	position: absolute;
	top: 16.4%;
	left: 0;
	right: 0;
	width: 100%;
}

/* .onekey-login-img {
    width: 75px;
    height: 75px;
    background: url("https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/images/sprite_wap_baike.png") no-repeat;
    background-size: 100px 91px;
    background-position: 0 0;
    background-repeat: no-repeat;
    margin: 0 auto;
} */

.onekey-login-title {
	text-align: center;
	padding-bottom: 3px;
	font-size: 21px;
	font-weight: bold;
	line-height: 30px;
	color: #000;
}

.onekey-login-txt {
	text-align: center;
	font-family: PingFangSC;
	font-size: 14px;
	line-height: 20px;
	color: #8f8f8f;
}

.onekey-login-qq,
.onekey-login-wx,
.onekey-login-phone {
	display: block;
	width: 245px;
	height: 54px;
	border-radius: 45px;
	text-align: center;

	margin: 0 auto;
	font-size: 17px;
	line-height: 24px;
	color: #000;
	/* padding: 16px 77px; */
	border-radius: 12px;
	border: solid 1px #e0e0e0;
}
.onekey-qq-content,
.onekey-vx-content,
.onekey-phone-content {
	display: inline-block;
	margin-top: 16px;
}
.onekey-qq-content {
	padding: 0 5px;
}

.onekey-login-qq {
	margin-top: 48px;
	margin-bottom: 24px;
}

.onekey-login-qq:before {
	display: inline-block;
	content: "";
	width: 20px;
	height: 20px;
	background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 80px;
	background-position: -20px 0;
	vertical-align: top;
	margin: 17px 8px 0 0;
}

.onekey-login-wx {
	margin-bottom: 24px;
}

.onekey-login-wx:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: 0 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-login-phone {
}

.onekey-login-phone:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: -42px 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-fixed {
	z-index: 100;
	position: fixed;
	top: 0;
	bottom: 0;
	left: 0;
	right: 0;
	background: #fff;
	width: 100%;
	height: 100%;
}

.onekey-fixed.forbid {
	z-index: 100;
	position: fixed;
	top: auto;
	bottom: 68px;
	left: 9%;
	right: 0;
	background: rgba(0, 0, 0, 0.7);
	width: 82%;
	height: 43px;
	border-radius: 25px;
	color: #ffffff;
}
.onekey-login-title.forbid {
	text-align: center;
	padding-bottom: 3px;
	font-size: 14px;
	font-weight: normal;
	line-height: 30px;
	color: white;
}
</style><style>#login_mask {
  background: #000;
  opacity: 0.5;
  filter: alpha(opacity=50);
  position: fixed;
  /*fixed好像在哪个IE上有BUG，先用用*/
  left: 0;
  top: 0;
  z-index: 999;
  height: 100%;
}

#login_iframe_container {
  position: fixed;
  width: 550px;
  height: 360px;
  z-index: 1020;
  background-color: #ffffff;
}

@media screen and (max-width: 828px) {
  #login_iframe_container {
    top: 50% !important;
    left: 50% !important;
    transform: translate(-50%, -50%);
  }
}

#login_iframe_container.new-login {
  width: 550px;
  height: 360px;
  background-image: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/background_2a4a8a6.png);
}

#login_iframe_container.new-login.no-bg {
  background: #fff;
}

#login_iframe_container.new-login .login-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 30px;
  letter-spacing: 0.19px;
  color: #ffffff;
  margin-top: 62px;
}
#login_iframe_container.new-login .forbid-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 24px;
  letter-spacing: 0.19px;
  color: #333333;
  margin-top: 150px;
}

#login_iframe_container.new-login.no-bg .login-title {
  color: #333333;
}

#login_iframe_container.new-login .login-subtitle {
  width: 100%;
  height: 18px;
  line-height: 18px;
  font-size: 13px;
  letter-spacing: 0.08px;
  color: #ffffff;
  text-align: center;
  margin-top: 9px;
  margin-bottom: 43px;
}

#login_iframe_container.new-login.no-bg .login-subtitle {
  color: #999999;
}

#login_iframe_container.new-login .login-subtitle::before {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: -5px;
}

#login_iframe_container.new-login .login-subtitle::after {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: 5px;
}

#login_iframe_container.new-login.no-bg .login-subtitle::before {
  background-color: #999999;
}

#login_iframe_container.new-login.no-bg .login-subtitle::after {
  background-color: #999999;
}

#login_iframe_container.new-login .close-btn {
  position: absolute;
  top: 20px;
  right: 20px;
  width: 12px;
  height: 12px;
  background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -59px -10px;
  background-size: 81px 91px;
  cursor: pointer;
}

#login_iframe_container.new-login .login-btn {
  width: 220px;
  height: 47px;
  border-radius: 24px;
  border: solid 1px #dddddd;
  background-color: #ffffff;
  margin: 0 auto;
  margin-top: 28px;
  position: relative;
  display: block;
}

#login_iframe_container.new-login .login-btn .login-icon {
  position: absolute;
}

#login_iframe_container.new-login .login-btn .login-text {
  width: 61px;
  height: 47px;
  line-height: 47px;
  vertical-align: middle;
  font-size: 15px;
  letter-spacing: 0.1px;
  color: #666666;
  position: absolute;
  right: 62px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-icon {
  width: 22px;
  height: 27px;
  top: 10px;
  left: 67px;
  background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -54px;
  background-size: 81px 91px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-text {
  right: 59px;
}

#login_iframe_container.new-login .login-btn.wechat-btn .login-icon {
  width: 29px;
  height: 24px;
  top: 12px;
  left: 62px;
  background: url(//web.archive.org/web/20221025113757/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -10px;
  background-size: 81px 91px;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style></head><body class=""><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
</style>
<script>__wm.rw(0);</script>
<div id="wm-ipp-base" lang="en" style="display: block; direction: ltr;">
</div><div id="wm-ipp-print">The Wayback Machine - https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/d11095.htm</div>
<script type="text/javascript">//<![CDATA[
__wm.bt(675,27,25,2,"web","https://baike.sogou.com/kexue/d11095.htm","20221025114441",1996,"/_static/",["/_static/css/banner-styles.css?v=S1zqJCYt","/_static/css/iconochive.css?v=qtvMKcIJ"], false);
  __wm.rw(1);
//]]></script>
<!-- END WAYBACK TOOLBAR INSERT --><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('83ac6a94fd884ce3959aafc40c6ec7c8') window._gtag.traceId = '83ac6a94fd884ce3959aafc40c6ec7c8';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="https://web.archive.org/web/20221025114441/https://www.sogou.com/web?query=">网页</a></li><li><a href="https://web.archive.org/web/20221025114441/https://weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="https://web.archive.org/web/20221025114441/https://zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="https://web.archive.org/web/20221025114441/https://pic.sogou.com/pics?query=">图片</a></li><li><a href="https://web.archive.org/web/20221025114441/https://v.sogou.com/v?query=">视频</a></li><li><a href="https://web.archive.org/web/20221025114441/https://mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="https://web.archive.org/web/20221025114441/https://hanyu.sogou.com/">汉语</a></li><li><a href="https://web.archive.org/web/20221025114441/https://wenwen.sogou.com/">问问</a></li><li><a href="https://web.archive.org/web/20221025114441/https://www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header"><div class="header-wrap"><a class="header-logo" href="https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"><form><input id="searchInput" class="query" type="text" placeholder="搜科学领域专业百科词条" name="query" autocomplete="off" value=""><a href="javascript:;" class="query-search"></a></form></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>再生障碍性贫血</h1><a href="https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/d11095.htm#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="54091978371030797"><div class="text_img ed_imgfloat_right"><a class="ed_image_link" data-src="https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg" data-bigsrc="https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg?width=227&amp;height=174&amp;titlename=&amp;w=346&amp;h=227" title="点击查看大图" data-w="346" data-h="227" style="background-image:url(https://web.archive.org/web/20221025114441im_/https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg)" href="https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/d11095.htm#!"></a></div><div><p>再生障碍性贫血 是一种人体不能产生足够数量血细胞的罕见疾病。血细胞是由骨髓中的造血干细胞生成<sup><a href="https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/d11095.htm#quote_1" class="kx_ref">[1]</a></sup> ，再生障碍性贫血导致所有类型的血细胞缺乏，包括红细胞、白细胞和血小板。 </p>
<p>再生障碍性贫血在十几岁和二十多岁的人群中更常见，同时在老年人中也很常见。它的病因可能为遗传因素、免疫疾病因素或接触化学品、药物或辐射。然而，约一半病因尚不清楚。 </p>
<p>再生障碍性贫血的确诊需要骨髓活检，正常骨髓中30-70%是造血干细胞，但在再生障碍性贫血患者骨髓中，造血干细胞大大减少并被脂肪取代。 </p>
<p>再生障碍性贫血的一线治疗包括免疫抑制药物，通常是抗淋巴细胞球蛋白或抗胸腺细胞球蛋白，联合皮质类固醇和环孢素。特别是对于30岁以下有合适骨髓供体的患者，可以使用造血干细胞移植。</p>
<p>埃莉诺·罗斯福和玛丽·居里的死因皆被认为是再生障碍性贫血。</p></div></div><div id="catalog"></div><div id="paragraphs"></div><div id="references"></div><div class="read-num">阅读 <!-- -->4122</div></div><div class="right-side" id="rightSide"></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://web.archive.org/web/20221025114441/https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://web.archive.org/web/20221025114441/https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="https://web.archive.org/web/20221025114441/http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="https://web.archive.org/web/20221025114441/http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://web.archive.org/web/20221025114441/https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"11095","versionId":"54091978371030788","title":"再生障碍性贫血","subtitle":"","abstracts":{"paragraphId":"54091978371030797","title":"摘要","versionId":"54091978371030789","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>再生障碍性贫血 是一种人体不能产生足够数量血细胞的罕见疾病。血细胞是由骨髓中的造血干细胞生成<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> ，再生障碍性贫血导致所有类型的血细胞缺乏，包括红细胞、白细胞和血小板。 </p>\n<p>再生障碍性贫血在十几岁和二十多岁的人群中更常见，同时在老年人中也很常见。它的病因可能为遗传因素、免疫疾病因素或接触化学品、药物或辐射。然而，约一半病因尚不清楚。 </p>\n<p>再生障碍性贫血的确诊需要骨髓活检，正常骨髓中30-70%是造血干细胞，但在再生障碍性贫血患者骨髓中，造血干细胞大大减少并被脂肪取代。 </p>\n<p>再生障碍性贫血的一线治疗包括免疫抑制药物，通常是抗淋巴细胞球蛋白或抗胸腺细胞球蛋白，联合皮质类固醇和环孢素。特别是对于30岁以下有合适骨髓供体的患者，可以使用造血干细胞移植。</p>\n<p>埃莉诺·罗斯福和玛丽·居里的死因皆被认为是再生障碍性贫血。</p>","pics":[{"originalUrl":"https://web.archive.org/web/20221025114441/https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg?width=227&height=174&titlename=&w=346&h=227","url":"https://web.archive.org/web/20221025114441/https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg","rw":346,"rh":227,"title":"","alt":null,"width":227,"height":174}],"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"14996318917231123","title":"基本信息","versionId":"54091978371030790","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":3,"content":"","pics":null,"card":{"cardItems":[{"key":"同义词","value":"再生障碍性贫血"},{"key":"医学专科","value":"肿瘤学，血液学"},{"key":"多发群体","value":"青壮年人"},{"key":"外文名","value":"aplastic anemia"}]},"references":[],"versionCount":0},"categories":[{"id":13,"name":"药学","parents":[]}],"creator":{"uid":76032588,"name":"朱丹","pic":"https://web.archive.org/web/20221025114441/https://cache.soso.com/qlogo/g?b=oidb&k=yrSO6VsQ7mjpcz0B3v2Ruw&s=100&t=1555724637","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":1571038564,"editor":{"uid":76032588,"name":"朱丹","pic":"https://web.archive.org/web/20221025114441/https://cache.soso.com/qlogo/g?b=oidb&k=yrSO6VsQ7mjpcz0B3v2Ruw&s=100&t=1555724637","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576234502,"state":1,"versionCount":1,"upNum":2,"downNum":0,"pics":[{"originalUrl":"https://web.archive.org/web/20221025114441/https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg?width=227&height=174&titlename=&w=346&h=227","url":"https://web.archive.org/web/20221025114441/https://img04.sogoucdn.com/app/a/200698/346_227_20200908115355-1517010214.jpg","rw":346,"rh":227,"title":"","alt":null,"width":227,"height":174}],"catalogs":[{"level":1,"title":"语源","paragraphId":"14996318934008321","subCatalogs":null},{"level":1,"title":"症状和体征","paragraphId":"14996318934008322","subCatalogs":null},{"level":1,"title":"病因","paragraphId":"14996318934008323","subCatalogs":null},{"level":1,"title":"诊断","paragraphId":"14996318950785543","subCatalogs":null},{"level":1,"title":"治疗","paragraphId":"14996318967562757","subCatalogs":[{"level":2,"title":"<b>随访</b>","paragraphId":"14996318967562757","subCatalogs":null}]},{"level":1,"title":"预后","paragraphId":"14996318967562758","subCatalogs":null},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null}],"paragraphs":[{"paragraphId":"14996318934008321","title":"语源","versionId":"54091978371030791","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>再生障碍是由古希腊的两个词组合而成:其中a-意为“不”，-plasis是指“形成一种形状” <sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup> 。贫血是由古希腊意为“非”的an-和希腊语<i>-(h)aimia</i>意为“血”的词演变的新拉丁语<i>-emia</i>组合而成。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14996318934008322","title":"症状和体征","versionId":"54091978371030792","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>贫血可能会导致乏力、皮肤苍白和心动过速。<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup> </p><p>血小板减少会增加出血、瘀伤和瘀点的风险。白细胞减少会增加感染的风险。<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14996318934008323","title":"病因","versionId":"54091978371030793","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>再生障碍性贫血可由接触某些化学物质、药物、辐射、感染、免疫疾病引起；约一半的已确诊病例病因尚不清楚。再生障碍性贫血是非家族遗传性和传染性疾病。但是一个人得了这种病可以通过其他条件获得,患者的后代也不会因为遗传原因获得该疾病。<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup><sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup> </p><p>再生障碍性贫血有时也与接触苯等毒素，或与使用某些药物有关，包括氯霉素、卡马西平、非氨酯、苯妥英钠、奎宁和保泰松。根据一些病理报告的反馈，许多药物与再生障碍性贫血形成相关，但风险非常低。例如，氯霉素治疗与再生障碍性贫血形成相关的风险低于1/40000,卡马西平造成的再生障碍性贫血更为罕见。<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup> </p><p>暴露于放射性物质或辐射制造装置的电离辐射也与再生障碍性贫血的形成有关。因放射性领域开创性工作而闻名的玛丽·居里(Marie Curie)，在长时间无保护地使用放射性物质后，死于再生障碍性贫血，而那时还不知道电离辐射的有害影响。<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup> </p><p>高达2%的急性病毒性肝炎患者患有再生障碍性贫血。<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup> </p><p>再生障碍性贫血形成的一个已知病因是白细胞攻击骨髓的自身免疫。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup> </p><p>重型再生障碍性贫血也可能是微小病毒感染的结果。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup> 在人类中，许多细胞受体中的一种构成人血型的抗原——P抗原(也称为红细胞糖苷酯)，是引起儿童传染性红斑(第五疾病)的微小病毒B19病毒的细胞受体。微小病毒由于对P抗原的亲和力而感染红细胞，导致红细胞生成完全停止。在大多数情况下，这样的情景很少被注意到，因为红细胞平均存活120天，生成减少不会显著影响循环红细胞的总数。然而，在红细胞早期死亡的情况下(如镰状细胞病)，微小病毒感染会导致严重贫血。</p><p>微小病毒B19更常见于仅涉及红细胞的再生障碍性危象 。再生障碍性贫血涉及所有不同的细胞系。</p><p>与再生障碍性贫血形成相关的病毒包括肝炎病毒、EB病毒、巨细胞病毒、微小病毒B19和艾滋病毒。</p><p>在一些动物中，再生障碍性贫血可能有其他原因。例如，在雪貂中，它是由雌激素毒性引起的，因为雌性雪貂通过诱发排卵的动物，所以需要交配是为了让雌性雪貂停止发情。动情的雌性雪貂，如果不交配，将会保持较高的发情状态，一段时间后，高水平的雌激素会导致骨髓停止产生红细胞。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14996318950785543","title":"诊断","versionId":"54091978371030794","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>再生障碍性贫血需要与单纯红细胞再生障碍性贫血区分开来。在再生障碍性贫血中，患者患有全血细胞减少症(即白细胞减少症和血小板减少症)，导致血液中的有形成分全部减少。相比而言，单纯红细胞再生障碍性贫血的特征仅因为红细胞减少。确诊只能通过骨髓活检。在活检之前，通常会对患者进行其他血液学检查以寻找诊断线索，包括全血细胞计数、肾功能和电解质、肝酶、甲状腺功能测试、维生素B12和叶酸水平。</p><p>以下检查有助于确定再生障碍性贫血的鉴别诊断:</p><p>\n <ol>\n  <li>骨髓穿刺和活检:排除全血细胞减少的其他原因(即肿瘤浸润或显著骨髓纤维化)。</li>\n  <li>医源性接触细胞毒性化疗病史:可导致短暂的骨髓抑制。</li>\n  <li>x光、计算机断层扫描（CT）或超声成像检查:淋巴结肿大(淋巴瘤体征)、肾脏和手臂和手掌的骨骼(范科尼贫血的异常体征)。</li>\n  <li>胸部x光检查:感染。</li>\n  <li>肝脏检查:肝脏疾病。</li>\n  <li>病毒检查:病毒感染。</li>\n  <li>维生素B12和叶酸水平:维生素缺乏。</li>\n  <li>阵发性睡眠性血红蛋白尿的血液检查。</li>\n  <li>抗体检查:免疫能力。</li>\n </ol></p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14996318967562757","title":"治疗","versionId":"54091978371030795","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>治疗免疫介导的再生障碍性贫血包括抑制免疫系统，需每日服药达到疗效，或者在更严重的情况下，骨髓移植是一种潜在的治疗方法。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup> 来自供体的移植的新骨髓细胞代替了衰竭的骨髓细胞。骨髓中的多能造血干细胞重新生成三种血细胞系，为患者提供了新的免疫系统、红细胞和血小板。然而，除了移植失败的风险之外，新产生的白细胞也有攻击身体其他部分的风险(“移植物抗宿主病”)。在有人类白细胞抗原匹配的兄弟姐妹供体的年轻患者中，骨髓移植可被视为一线治疗，缺乏匹配的兄弟姐妹供体的患者通常选择免疫抑制作为一线治疗，而匹配的非兄弟姐妹的供体移植则被视为二线治疗。</p><p>再生障碍性贫血的药物治疗通常包括一个疗程抗胸腺细胞球蛋白(ATG)和几个月环孢菌素，用于调节免疫系统。用环磷酰胺等药物进行化疗也可能有效，但毒性比ATG更大。靶细胞为T细胞的抗体疗法，如ATG，被认为是攻击骨髓细胞的。皮质类固醇通常无效，尽管它们被用于改善ATG引起的血清疾病。通常情况下，在初次接受ATG治疗6个月后，通过骨髓活检来判断是否成功。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup> </p><p>一项涉及环磷酰胺的前瞻性研究因死亡率高而提前终止，死亡率高的原因是由于长期中性粒细胞减少导致的严重感染。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup> </p><p>过去，在采用上述治疗之前，白细胞计数低的患者通常被限制在无菌室 (以降低感染风险)，如泰德·迪瓦塔(Ted DeVita)的情况。<sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup> </p><p><h3><b>随访</b></h3></p><p>需要定期进行全血计数，以确定患者是否仍处于缓解状态。</p><p>许多再生障碍性贫血患者也有罕见疾病阵发性睡眠性血红蛋白尿(PNH，伴有血小板减少和/或血栓形成的贫血)的细胞克隆特征，有时被简称为AA/PNH。随着时间的推移，PNH偶尔占主导地位，主要表现为血管内溶血。据推测，AA和PNH的重叠是骨髓抵御免疫系统破坏的逃逸机制。有再生障碍性贫血病史的人定期进行流式细胞术检测，以监测PNH形成。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14996318967562758","title":"预后","versionId":"54091978371030796","lemmaId":11095,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599537331,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>未经治疗的重型再生障碍性贫血有很高的死亡风险。通过药物或造血干细胞移植的现代疗法，五年存活率超过85%，年龄越小存活率越高。<sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup> </p><p>造血干细胞移植的存活率因年龄和匹配良好的供体的可得性而异。接受移植的病人的五年存活率显示，20岁以下的病人为82%，20-40岁的病人为72%，40岁以上的病人接近50%。对于有兄弟姐妹供体的患者来说成功率更高，对接受非兄弟姐妹配型的骨髓的病人来说更低。<sup><a href=\"#quote_13\" class=\"kx_ref\">[13]</a></sup> </p><p>老年人(通常太虚弱而无法接受骨髓移植)和无法找到良好骨髓配型的患者，接受免疫抑制的五年存活率高达75%。</p><p>再生障碍性贫血的复发很常见。使用ATG/环孢素后复发有时可以通过重复疗程进行治疗。此外，10-15%的重型再生障碍性贫血病例发展为骨髓增生异常综合征和白血病。根据一项研究，对于接受免疫抑制治疗的儿童，约15.9%对免疫抑制治疗有反应的儿童会复发。<sup><a href=\"#quote_14\" class=\"kx_ref\">[14]</a></sup> </p><p>轻型再生障碍性贫血可以自愈。</p>","pics":null,"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"book","title":"Acton, Ashton (22 July 2013). Aplastic Anemia. ScholarlyEditions. p. 36. ISBN 978-1-4816-5068-7. Aplastic anaemia (AA) is a rare bone marrow failure disorder with high mortality rate, which is characterized by pancytopenia and an associated increase in the risk of hemorrhage, infection, organ dysfunction and death.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":2,"type":"book","title":"Flexner, Stuart; Hauck, Leonore, eds. (1993). Random House Unabridged Dictionary (in English) (2nd ed.). New York City: Random House. p. 98. ISBN 0-679-42917-4.CS1 maint: Unrecognized language (link)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":3,"type":"book","title":"Flexner, Stuart; Hauck, Leonore, eds. (1993). Random House Unabridged Dictionary (in English) (2nd ed.). New York City: Random House. p. 78. ISBN 0-679-42917-4.CS1 maint: Unrecognized language (link)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":4,"type":"book","title":"Peinemann, F; Bartel, C; Grouven, U (23 July 2013). \"First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia\". The Cochrane Database of Systematic Reviews. 7 (7): CD006407. doi:10.1002/14651858.CD006407.pub2. PMID 23881658.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":5,"type":"book","title":"Kasper, Dennis L; Braunwald, Eugene; Fauci, Anthony; et al. (2005). Harrison's Principles of Internal Medicine, 16th ed. New York: McGraw-Hill. ISBN 978-0-07-140235-4.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":6,"type":"book","title":"\"Marie Curie - The Radium Institute (1919-1934): Part 3\". American Institute of Physics.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":7,"type":"book","title":"Clark, Michael; Kumar, Parveen, eds. (July 2011). Kumar & Clark's clinical medicine (7th ed.). Edinburgh: Saunders Elsevier. ISBN 978-0-7020-2992-9.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":8,"type":"book","title":"Young, Neal S. (2018-10-25). \"Aplastic Anemia\". The New England Journal of Medicine. 379 (17): 1643–1656. doi:10.1056/NEJMra1413485. ISSN 1533-4406. PMID 30354958.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":9,"type":"book","title":"Locasciulli A, Oneto R, Bacigalupo A, et al. (2007). \"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)\". Haematologica. 92 (1): 11–8. doi:10.3324/haematol.10075. PMID 17229630.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":10,"type":"book","title":"Tisdale JF, Maciejewski JP, Nunez O, et al. (2002). \"Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial\". Blood. 100 (13): 4668–4670. doi:10.1182/blood-2002-02-0494. PMID 12393567.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":11,"type":"book","title":"\"NIH Clinical Center: Clinical Center News, NIH Clinical Center\". Retrieved 2007-12-04.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":12,"type":"book","title":"DeZern, Amy E; Brodsky, Robert A (10 January 2014). \"Clinical management of aplastic anemia\". Expert Review of Hematology. 4 (2): 221–230. doi:10.1586/ehm.11.11. PMC 3138728.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":13,"type":"book","title":"Scheinberg, Phillip; Young, Neal S. (April 19, 2012). \"How I treat acquired aplastic anemia\". Blood. 120 (6): 1185–96. doi:10.1182/blood-2011-12-274019. PMC 3418715. PMID 22517900. Free Text","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":14,"type":"book","title":"Kamio, T.; Ito, E.; Ohara, A.; Kosaka, Y.; Tsuchida, M.; Yagasaki, H.; Mugishima, H.; Yabe, H.; Morimoto, A.; Ohga, S.; Muramatsu, H.; Hama, A.; Kaneko, T.; Nagasawa, M.; Kikuta, A.; Osugi, Y.; Bessho, F.; Nakahata, T.; Tsukimoto, I.; Kojima, S. (21 March 2011). \"Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group\". Haematologica. 96 (6): 814–819. doi:10.3324/haematol.2010.035600. PMC 3105642. PMID 21422115. In the present study, the cumulative incidence of relapse at 10 years was relatively low compared to that in other studies mainly involving adult patients. A multicenter prospective study is warranted to establish optimal therapy for children with aplastic anemia.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false}],"recommendReferences":null,"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":4122,"auditType":0,"synonyms":["aplastic anemia","再生障碍贫血","再生障碍性贫血症状","再生性障碍性贫血","再障","再生障碍性","再生性贫血障碍","障碍性再生贫血","再障性贫血"],"showEditTime":"2019.12.13 18:55","auditors":[{"uid":0,"name":"Ki.κe","pic":"https://web.archive.org/web/20221025114441/https://wx.qlogo.cn/mmopen/vi_32/y67kfr32Doib4wg71Jiau7jVWvharic3nRKgdRRQSl6koeQJCo0GQs2Krw0vwdFRsOWnHIQOwAZsSg5lIkIrFCOcQ/132","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false}],"hasZhishiNav":false,"auditInfos":{},"isHistory":false};</script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/aegis.min.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/main_2020092401.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/jquery-1.11.1.min.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/main_2022062701.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/main_66bbe21.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./1095.再生障碍性贫血 - 搜狗科学百科_files/main_edf0f08.js.download"></script>
</body></html>